Search

Displaying results 281 - 290 of 5449 in total
  1. Drug

    Latanoprost

    go.drugbank.com/drugs/DB00654
    ApprovedInvestigational

    Another benefit latanoprost is that it can be administered once a day.[A184490] … It was initially approved by the FDA in 1998. Latanoprost is the first topical prostaglandin F2 alpha analog used for glaucoma treatment.

    Mixtures: LATANOPROST 0.05 MG/ML AND TIMOLOL 5 MG/ML SANDOZ EYE DROPS, PROSTACOM (LATANOPROST 0.05 MG/ML AND TIMOLOL 5MG/ML, EYE DROPS)Products: Vizilatan 0,05 mg/ml Augentropfen, Lösung, PROSDROP EYE DROPS SOLUTION 0.05 MG/ML
  2. Drug

    Disopyramide

    go.drugbank.com/drugs/DB00280
    ApprovedInvestigational

    It also possesses some anticholinergic and local anesthetic properties.

    Products: Disopyramide Phosphate ER, NORPACE 100 MG KAPSÜL, 25 ADET
  3. Drug

    Eribulin

    go.drugbank.com/drugs/DB08871
    ApprovedInvestigational

    Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic

    Products: ERIBULINA EG, HALAVEN 0.5 mg/ml solution for injection
  4. Drug

    Lapatinib

    go.drugbank.com/drugs/DB01259
    ApprovedInvestigational

    It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding. … It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine.

    Products: TYKERB 250 MG FILM TABLET, 70 ADET, LAPATINIB EG
  5. Drug

    Eszopiclone

    go.drugbank.com/drugs/DB00402
    ApprovedInvestigational

    It is the active stereoisomer of zopiclone, belonging to the class of drugs known as _cyclopyrrolones_. … One major benefit of eszopiclone is that it is approved by the FDA for the long-term treatment of insomnia.

    Products: DORMEBEN® EZ 2 MG TABLETAS RECUBIERTAS., DORMEBEN® EZ 3 MG TABLETAS RECUBIERTAS
  6. Drug

    Almotriptan

    go.drugbank.com/drugs/DB00918
    Approved

    It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms

    Products: ALMOTRIPTAN EG
  7. Drug

    Omega-3 fatty acids

    go.drugbank.com/drugs/DB11133
    ApprovedInvestigationalNutraceutical

    Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain.

    Mixtures: SetonET-EC, PR Natal 430 ecProducts: EPAX720 MG, OMEGA 3 EG
  8. Drug

    Manidipine

    go.drugbank.com/drugs/DB09238
    ApprovedInvestigationalWithdrawn

    It is selective for vasculature and does not produce effects on the heart at clinically relevant dosages.

    Products: IPERTEN 20 MG TABLET, 28 ADET, MANIDIPINA EG
  9. Drug

    Carbamazepine

    go.drugbank.com/drugs/DB00564
    ApprovedInvestigational

    It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.

    Products: Carbamazepine ER, CarbamazepineER ER
  10. Drug

    Selegiline

    go.drugbank.com/drugs/DB01037
    ApprovedInvestigationalVet approved

    It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. … It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

    Products: SELEGILINA EG, Eldepryl Tab 5mg